Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
Go back to Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform| (NASDAQ: LTRN) | Delayed: 1.84 -0.07 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.91 | 52 Week High | $ | |||
| Open | $1.86 | 52 Week Low | $ | |||
| Day High | $2.01 | P/E | N/A | |||
| Day Low | $1.83 | EPS | $ | |||
| Volume | 242,572 | |||||

